Clinicopathological Study of Mucinous Carcinoma of Breast with Emphasis on Cytological Features: A Study at Tertiary Care Teaching Hospital of South India

Abstract

Introduction Mucinous carcinoma (MC) is a rare form of breast cancer. It accounts for 1 to 7% of the cases and characterized by the presence of extracellular mucin (ECM). Depending on the amount of mucin, it is classified into pure mucinous carcinoma (> 90%, PMC) and mixed mucinous carcinoma (MMC; < 90%). In comparison to most common subtypes, MC is having better prognosis. There exist clinicopathological differences among PMC and MMC and also MC and IDC-NOS.

Materials and Methods MCs diagnosed between January 2012 and December 2017 were included. Fine needle aspiration cytology smears were screened for cellularity, ECM, nuclear pleomorphism, signet ring cells (SRC), mucinophages, and myxovascular fragments (MVF). Histopathology slides were screened to confirm the diagnosis. Immunohistochemistry slides were graded as per the standard protocol. Statistical analyses were performed by SPSS software.

Results In the present study, MC constituted 3.3%. The mean age of the patients was 50.9 years. ECM, mucinophages, and SRC were the key diagnostic cytological features. The PMC and MMC were clinicopathologically distinct with respect to gross findings and lymph node status. MMCs were highly proliferative. The mean duration of follow-up was 24.5 months. Complications were more common in MMC than PMC. Lymph node involvement is the key prognostic factor and it is independent of other prognostic factors like age, size, and hormonal receptor status.

Conclusion PMC are rare subtype of breast cancer. The diagnostic cytological features are ECM, MVF, and SRC. MMC and PMC are clinicopathologically and genetically distinct.

Keywords

breast carcinoma - mucinous carcinoma - FNAC - extracellular mucin - mucinophages - signet ring cells - myxovascular fragments

Publication History

Article published online:
11 August 2020

• References

• 1 Tseng HS, Lin C, Chan SE. et al. Pure mucinous carcinoma of the breast: clinicopathologic characteristics and long-term outcome among Taiwanese women. World J Surg Oncol 2013; 11: 139
• 2 Bae SY, Choi MY, Cho DH, Lee JE, Nam SJ, Yang JH. Mucinous carcinoma of the breast in comparison with invasive ductal carcinoma: clinicopathologic characteristics and prognosis. J Breast Cancer 2011; 14 (04) 308-313
• 3 Dumitru A, Procop A, Iliesiu A. et al. Mucinous breast cancer: a review study of 5 year experience from a hospital-based series of cases. Maedica (Buchar) 2015; 10 (01) 14-18
• 4 Lei L, Yu X, Chen B, Chen Z, Wang X. Clinicopathological characteristics of mucinous breast cancer: a retrospective analysis of a 10-year study. PLoS One 2016; 11 (05) e0155132
• 5 Tyagi R, Kumar M, Tanwar P, Dey P. Mucinous carcinoma of breast: FNAC as effective diagnostic modality. Asian J Med Sci 2012; 11: 32-35
• 6 Jayaram G, Swain M, Chew MT, Yip CH, Moosa F. Cytology of mucinous carcinoma of breast: a report of 28 cases with histological correlation. Malays J Pathol 2000; 22 (02) 65-71
• 7 Adhikari RC, Jha A, Sayami G. Fine needle aspiration cytology findings of mucinous carcinoma of breast: a study of eight cases with histological correlation. J Pathol Nepal 2012; 2: 285-288
• 8 Ingle AP, Kulkarni AS, Patil SP, Kumbhakarna NR, Bindu RS. Mucinous carcinoma of the male breast with axillary lymph node metastasis: report of a case based on fine needle aspiration cytology. J Cytol 2012; 29 (01) 72-74
• 9 Sharma S, Bansal R, Khare A, Agrawal N. Mucinous carcinoma of breast: cytodiagnosis of a case. J Cytol 2011; 28 (01) 42-44
• 10 Nayak SK, Naik R, Upadhyaya K, Raghuveer CV, Pai MR. FNAC diagnosis of mucinous carcinoma of male breast—a case report. Indian J Pathol Microbiol 2001; 44 (03) 355-357
• 11 Haji BE, Das DK, Al-Ayadhy B. et al. Fine-needle aspiration cytologic features of four special types of breast cancers: mucinous, medullary, apocrine, and papillary. Diagn Cytopathol 2007; 35 (07) 408-416
• 12 Fujii H, Anbazhagan R, Bornman DM, Garrett ES, Perlman E, Gabrielson E. Mucinous cancers have fewer genomic alterations than more common classes of breast cancer. Breast Cancer Res Treat 2002; 76 (03) 255-260
• 13 Lacroix-Triki M, Suarez PH, MacKay A. et al. Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type. J Pathol 2010; 222 (03) 282-298
• 14 Cao AY, He M, Liu ZB. et al. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China. Ann Surg Oncol 2012; 19 (09) 3019-3027
• 15 Avisar E, Khan MA, Axelrod D, Oza K. Pure mucinous carcinoma of the breast: a clinicopathologic correlation study. Ann Surg Oncol 1998; 5 (05) 447-451
• 16 Di S Saverio, Gutierrez J, Avisar E. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Breast Cancer Res Treat 2008; 111 (03) 541-547
• 17 Toikkanen S, Kujari H. Pure and mixed mucinous carcinomas of the breast: a clinicopathologic analysis of 61 cases with long-term follow-up. Hum Pathol 1989; 20 (08) 758-764
• 18 García-Labastida L, Garza-Guajardo R, Barboza-Quintana O. et al. CDX-2, MUC-2 and B-catenin as intestinal markers in pure mucinous carcinoma of the breast. Biol Res 2014; 47: 43